Benefits of donepezil on cognition, function and neuropsychiatric symptoms in patients with mild and moderate Alzheimr´s disease over one year

Julkaisu

Reference

Waldemar G, Winblad B, Engedal K, Soininen H, Verhey F, Wimo A, Wetterholm A-L, Zhang R, Haglund A, Subbiah P, The Donepezil Nordic Study Group. Benefits of donepezil on cognition, function and neuropsychiatric symptoms in patients with mild and moderate Alzheimr´s disease over one year. In: Igbal K, Sisodia SS, Winblad B, eds. Alzheimer´s Disease: Advances in Ethiology, Pathogenesis and Therapeutics, p. 725-738. New York: John Wiley & Sons, 2001.